icometrix is working on the elaboration of icompanion.ms, a digital patient platform that has been developed for people living with multiple sclerosis as part of the EU CrossCare project.
MS is a chronic and incurable disease. Treatment decisions are taken by neurologists on the basis of various data, including MRI scans and standardized tests that are performed in the hospital. Nowadays, however, there is a demand for more detailed information that only the patient can give, also called patient reported outcomes (PROs).
The aim of icompanion.ms is to give people living with MS and their treating neurologists more insights into the patient's course during his / her daily life. This is done by collecting PROs on the digital patient platform icompanion.ms.
Together with the CrossCare ‘proeftuinen’, icometrix will evaluate the patient platform icompanion.ms and collect structured feedback through focus groups and user sessions. To this end, de ‘proeftuinen’ together with icometrix will combine efforts: user tests, live testing in the home environment, and co-creations with doctors and other stakeholders. The result of this co-creation between patients, neurologists, developers and researchers is a user-friendly application for a better understanding of the disease progression of people with MS in order to help doctors make better treatment decisions.Partners
This project is part of a cross-border collaboration with experimental gardens InnovAge (Leuven, Belgium) and Care Innovation Center (West-Brabant, the Netherlands). Thanks to this international collaboration, the value of PROs can be developed and evaluated in various healthcare systems.
The project is financed via the framework CrossCare from the European Interreg Flanders-Netherlands program (www.grensregio.eu). Interreg Vlaanderen-Nederland promotes cross-border projects for smart, green and inclusive growth, from the European Regional Development Fund (ERDF).